Connection

Elizabeth Garrett-Mayer to Receptor Protein-Tyrosine Kinases

This is a "connection" page, showing publications Elizabeth Garrett-Mayer has written about Receptor Protein-Tyrosine Kinases.
  1. A FLT3 tyrosine kinase inhibitor is selectively cytotoxic to acute myeloid leukemia blasts harboring FLT3 internal tandem duplication mutations. Blood. 2001 Aug 01; 98(3):885-7.
    View in: PubMed
    Score: 0.045
  2. Functional oncogene signatures guide rationally designed combination therapies to synergistically induce breast cancer cell death. Oncotarget. 2016 Jun 14; 7(24):36138-36153.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.